The predictive marker for detecting T790M from a patient background before treatment in stage4 NSCLC patients harboring EGFR mutaiton (L858R and delition 19): HOPE-002
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000041474
- Lead Sponsor
- Osaka International Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
recurrent patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the predictive marker for detecting T790M from the patient background in stage4 NSCLC patients harbering EGFR mutation
- Secondary Outcome Measures
Name Time Method